Creating tools to detect immune responses to SARS-CoV-2
NIH TCF Dev and Prod of SARS-CoV-2 Spike tetramers for B Cell Detection
This study is working on creating special proteins that help scientists and doctors better understand how our immune system fights COVID-19, so they can improve tests and treatments for people affected by the virus.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10282181 on NIH RePORTER |
What this research studies
This research focuses on developing and producing specialized proteins called tetramers that can help identify and analyze specific immune cells, particularly B cells and T cells, that respond to the SARS-CoV-2 virus. By creating these tetramers, the research aims to enhance our understanding of how the immune system reacts to COVID-19 and potential vaccines. The tetramers will be distributed to researchers and healthcare providers to facilitate studies on immune responses in patients affected by COVID-19. This work is crucial for improving diagnostic and therapeutic strategies against the virus.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have been infected with SARS-CoV-2 or are participating in COVID-19 vaccine trials.
Not a fit: Patients who have not been exposed to SARS-CoV-2 or are not involved in related research may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better tools for diagnosing and understanding immune responses in COVID-19 patients, potentially improving treatment outcomes.
How similar studies have performed: Other research has successfully utilized similar tetramer technology to study immune responses, indicating a promising approach for this investigation.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Altman, John — Emory University
- Study coordinator: Altman, John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.